Evoke Pharma Overview
- Year Founded
-
2007
- Status
-
Public
- Employees
-
4
- Stock Symbol
-
EVOK
- Share Price
-
$4.22
- (As of Monday Closing)
Evoke Pharma General Information
Description
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
Contact Information
Website
www.evokepharma.comCorporate Office
- 505 Lomas Santa Fe Drive
- Suite 270
- Solana Beach, CA 92075
- United States
Corporate Office
- 505 Lomas Santa Fe Drive
- Suite 270
- Solana Beach, CA 92075
- United States
Evoke Pharma Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.22 | $4.31 | $3.54 - $18.60 | $3.46M | 819K | 62K | -$45.48 |
Evoke Pharma Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | (155) | 2,560 | 1,763 | 11,868 |
| Revenue | 7,526 | 5,181 | 2,509 | 1,618 |
| EBITDA | (6,216) | (7,431) | (7,786) | (8,047) |
| Net Income | (6,528) | (7,792) | (8,224) | (8,538) |
| Total Assets | 12,136 | 7,069 | 11,851 | 10,573 |
| Total Debt | 5,000 | 5,000 | 5,129 | 5,012 |
Evoke Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Evoke Pharma Comparisons
Industry
Financing
Details
000000
000000
Evoke Pharma Competitors (41)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Alcresta Therapeutics | Private Equity-Backed | Waltham, MA | 00 | 000.00 | 000000000000 | 000.00 |
| Mirum Pharmaceuticals | Formerly VC-backed | Foster City, CA | 000 | 00000 | 000000000 | 00000 |
| Phathom Pharmaceuticals | Formerly VC-backed | Florham Park, NJ | 000 | 00000 | 00000000 | 00000 |
| Ardelyx | Formerly VC-backed | Fremont, CA | 000 | 00000 | 000000000 00 | 00000 |
Evoke Pharma Patents
Evoke Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200276139-A1 | Methods of intranasal metoclopramide dosing | Inactive | 11-Sep-2017 | 0000000000 | |
| CA-3075407-A1 | Methods of intranasal metoclopramide dosing | Pending | 11-Sep-2017 | 0000000000 | |
| EP-3681573-A1 | Methods of intranasal metoclopramide dosing | Inactive | 11-Sep-2017 | 0000000000 | |
| EP-3681573-A4 | Methods of intranasal metoclopramide dosing | Inactive | 11-Sep-2017 | 0000000000 | 0 |
| CA-3047088-A1 | Treatment of moderate and severe gastroparesis | Pending | 15-Dec-2016 | A61K31/166 |
Evoke Pharma Executive Team (3)
| Name | Title | Board Seat |
|---|---|---|
| Matthew D'Onofrio | Chief Executive Officer & Chief Accounting Officer, Accounting | |
| Mark Kowieski | Chief Financial Officer |
Evoke Pharma Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Cam Garner | Evoke Pharma | Chairman & Founder | 000 0000 |
| Kenneth Widder MD | Latterell Venture Partners | Board Member | 000 0000 |
| Todd Brady Ph.D | Self | Independent Director | 000 0000 |
| Vickie Reed | Self | Board Member | 000 0000 |
Evoke Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Evoke Pharma FAQs
-
When was Evoke Pharma founded?
Evoke Pharma was founded in 2007.
-
Who is the founder of Evoke Pharma?
David Gonyer is the founder of Evoke Pharma.
-
Who is the CEO of Evoke Pharma?
Matthew D'Onofrio is the CEO of Evoke Pharma.
-
Where is Evoke Pharma headquartered?
Evoke Pharma is headquartered in Solana Beach, CA.
-
What is the size of Evoke Pharma?
Evoke Pharma has 4 total employees.
-
What industry is Evoke Pharma in?
Evoke Pharma’s primary industry is Pharmaceuticals.
-
Is Evoke Pharma a private or public company?
Evoke Pharma is a Public company.
-
What is Evoke Pharma’s stock symbol?
The ticker symbol for Evoke Pharma is EVOK.
-
What is the current stock price of Evoke Pharma?
As of 16-Sep-2024 the stock price of Evoke Pharma is $4.22.
-
What is the current market cap of Evoke Pharma?
The current market capitalization of Evoke Pharma is $3.46M.
-
What is Evoke Pharma’s current revenue?
The trailing twelve month revenue for Evoke Pharma is $7.53M.
-
Who are Evoke Pharma’s competitors?
Pfizer Pakistan, Alcresta Therapeutics, Mirum Pharmaceuticals, Phathom Pharmaceuticals, and Ardelyx are some of the 41 competitors of Evoke Pharma.
-
What is Evoke Pharma’s annual earnings per share (EPS)?
Evoke Pharma’s EPS for 12 months was -$45.48.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
